NY-ESO-1 protein vaccine plus Montanide ISA-51 VG

{
  "id": "MLC-T-ONC-015564",
  "term": "NY-ESO-1 protein vaccine plus Montanide ISA-51 VG",
  "field": "Oncology and biomedicine",
  "definition": "A cancer vaccine consisting of an immunogenic peptide derived from the cancer-testis antigen (NY-ESO-1) and emulsified in the immunoadjuvant Montanide ISA-51 VG, with potential immunomodulating and antineoplastic activities. Upon subcutaneous vaccination, the NY-ESO-1 protein vaccine emulsified in Montanide ISA-51 VG may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) response against tumor cells expressing the NY-ESO-1 antigen, resulting in tumor cell lysis. NY-ESO-1, an antigen found in normal testes and various tumors, including bladder, breast, hepatocellular, melanoma, and prostate cancers. The surfactant mannide monooleate in Montanide ISA 51 VG is derived from vegetable-grade (VG) oleic acid that was purified from olive oil.",
  "synonyms": [
    "NY-ESO-1 protein vaccine emulsified In Montanide ISA-51 VG"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/ny-eso-1-protein-vaccine-plus-montanide-isa-51-vg/"
}